Developing early trials to prevent obesity-related cancers
Early Phase Clinical Cancer Prevention Consortium
This study is looking for ways to prevent certain cancers linked to obesity by focusing on special cancer cells, and it invites patients to join in testing new methods that could help lower the risk of cancers like breast, bladder, and colon cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10886009 on NIH RePORTER |
What this research studies
This research focuses on early clinical trials aimed at preventing cancers associated with obesity by targeting stem-like cancer cells. It investigates how chronic inflammatory stress, such as that caused by obesity and exposure to certain chemicals, can lead to increased cancer cell growth. The consortium plans to conduct multiple trials each year, testing various preventive agents that may help reduce the risk of cancers like breast, bladder, and colon cancer. Patients may have the opportunity to participate in these trials and contribute to the development of new cancer prevention strategies.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals at high risk for obesity-related cancers, particularly those with obesity or metabolic syndrome.
Not a fit: Patients who do not have obesity or related risk factors for the cancers being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new preventive treatments for obesity-related cancers, potentially reducing cancer incidence in at-risk populations.
How similar studies have performed: Other research has shown promise in targeting stem-like cancer cells for prevention, suggesting that this approach may be effective.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Schuetze, Scott Michael — University of Michigan at Ann Arbor
- Study coordinator: Schuetze, Scott Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.